fax: (203) 785-7273
Liver Failure/Cirrhosis/Portal Hypertension
Article first published online: 26 JUN 2011
Copyright © 2011 American Association for the Study of Liver Diseases
Volume 54, Issue 2, pages 555–561, August 2011
How to Cite
Berzigotti, A., Garcia-Tsao, G., Bosch, J., Grace, N. D., Burroughs, A. K., Morillas, R., Escorsell, A., Garcia-Pagan, J. C., Patch, D., Matloff, D. S., Groszmann, R. J. and the Portal Hypertension Collaborative Group (2011), Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology, 54: 555–561. doi: 10.1002/hep.24418
Potential conflict of interest: Dr. Bosch is a consultant for Nicox and Chiasma. He is also a consultant for and received grants from Astellas.
Supported by grants from the National Institutes of Health (RO1 DK46580, P30 DK34989 and K24 DK02727-02), and from the Instituto de Salud Carlos III (FIS 09/1261 to J.B.). CIBERehd is funded by Instituto de Salud Carlos III. Dr. Garcia-Tsao had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
- Issue published online: 25 JUL 2011
- Article first published online: 26 JUN 2011
- Accepted manuscript online: 12 MAY 2011 02:03PM EST
- Manuscript Accepted: 25 APR 2011
- Manuscript Received: 16 JAN 2011
Obesity is associated with an aggressive course in chronic viral hepatitis; however, its impact in the development of clinical decompensation (CD) in patients with established cirrhosis is uncertain. We evaluated the role of obesity, in relationship to other recognized predictors, in the development of CD in patients with compensated cirrhosis. The study population, a subset of patients included in a randomized trial of beta-blockers in the prevention of varices in whom data on body mass index (BMI) was available, consisted of 161 patients with compensated cirrhosis. Laboratory tests and portal pressure (assessed by the hepatic venous pressure gradient or HVPG) were assessed on inclusion. Patients were followed until CD (ascites, hepatic encephalopathy, or variceal hemorrhage), or until September 2002. Altogether, 29% had a normal BMI, 40% were overweight, and 30% were obese. In a median follow-up of 59 months, CD occurred in 48/161 (30%) patients with an increasingly higher rate according to BMI group (15% in those with normal BMI; 31% in overweight; 43% in obese patients, P = 0.011). The actuarial probability of developing CD was significantly higher in the abnormal BMI groups (P = 0.022). In a multivariate model that included parameters previously identified as being predictive of CD (HVPG, albumin, Mayo endstage liver disease score), etiology, and treatment group, BMI (hazard ration 1.06; 95% confidence interval 1.01-1.12), P = 0.02] was an independent predictor of decompensation, together with HVPG and albumin. Conclusion: Obesity has a deleterious effect on the natural history of compensated cirrhosis of all etiologies, independent of portal pressure and liver function. Weight reduction may be a valuable therapeutic measure in this patient population. (HEPATOLOGY 2011;)